Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00171301

NCT00171301
Completed Phase 4

Who may be able to join

Who might be able to join this trial:

  • You must have already completed the full 12-month main study (NCT00171171).
  • Female patients who have had their first period and are sexually active must be using an effective form of birth control, or must have had a procedure such as removal of the uterus and/or ovaries, or tubal ligation.
  • You (and/or your legal guardian, if applicable) must have signed a consent form agreeing to take part, following the rules of your country.

Who may not be able to join:

  • You cannot join if you are currently pregnant or breastfeeding.
  • You may not be able to join if the trial doctor feels you may have difficulty following the study rules or cooperating with the study requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 4
Sponsor
Novartis Pharmaceuticals
Registry
clinicaltrials_gov
Start date
1 June 2005
Est. completion
1 May 2008

Where this trial is recruiting

🇪🇬 Egypt 🇱🇧 Lebanon Oman 🇸🇦 Saudi Arabia Syria

Primary endpoints

Percentage of Participants With Treatment Success From Core Baseline (BL) to Extension End of Study, by Baseline LIC Level and Age; Absolute Change in Liver Iron Concentration (LIC)Measured by Liver MRI or Liver Biopsy From Core Study Baseline (BL) to End of Extension Study, by LIC Category

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov